Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effects of Atazanavir-induced Hyperbilirubinemia on the Innate Immune Response During Human Endotoxemia. A Parallel Double Blind Placebo Controlled Pilot Study.

NCT00916448 is registered in ClinicalTrials.gov with Radboud University Medical Center as lead sponsor.

NCT NCT00916448
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00916448 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effects of Atazanavir-induced Hyperbilirubinemia on the Innate Immune Response During Human Endotoxemia. A Parallel Double Blind Placebo Controlled Pilot Study.
Lead sponsor
Radboud University Medical Center
Phase
Not applicable
Overall status
Completed
Start date
May 31, 2009
Completion date
July 31, 2015
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

endotoxemia, inflammation, multi organ dysfunction syndrome, sepsis